tiprankstipranks
Advertisement
Advertisement

HK:1093 Stock Latest News

CSPC Wins China Approval for Ustekinumab Biosimilar Enyike, Expanding Autoimmune Portfolio
Company AnnouncementsCSPC Wins China Approval for Ustekinumab Biosimilar Enyike, Expanding Autoimmune Portfolio
1d ago
CSPC Wins China Approval for Targeted Budesonide Capsule in IgA Nephropathy
PremiumCompany Announcements
CSPC Wins China Approval for Targeted Budesonide Capsule in IgA Nephropathy
2d ago
CSPC Wins China Trial Nod for First-in-Class KAT6 Cancer Drug
PremiumCompany Announcements
CSPC Wins China Trial Nod for First-in-Class KAT6 Cancer Drug
5d ago
CSPC Pharmaceutical Schedules Board Meeting to Approve Q1 2026 Results
PremiumCompany Announcements
CSPC Pharmaceutical Schedules Board Meeting to Approve Q1 2026 Results
9d ago
CSPC’s ADC SYS6010 Wins New Breakthrough Status in China Esophageal Cancer
PremiumCompany Announcements
CSPC’s ADC SYS6010 Wins New Breakthrough Status in China Esophageal Cancer
12d ago
CSPC Wins U.S. and China Trial Approvals for New Oncology Antibody-Drug Conjugate
PremiumCompany AnnouncementsCSPC Wins U.S. and China Trial Approvals for New Oncology Antibody-Drug Conjugate
24d ago
CSPC Wins Historic EU Approval for Chinese-Made Liposomal Antifungal
Premium
Company Announcements
CSPC Wins Historic EU Approval for Chinese-Made Liposomal Antifungal
24d ago
CSPC Pharmaceutical Sets 2026 AGM to Approve Dividend, Board Mandates and Share Buy-Back
Premium
Company Announcements
CSPC Pharmaceutical Sets 2026 AGM to Approve Dividend, Board Mandates and Share Buy-Back
25d ago
CSPC Innovation Posts Strong Revenue Growth but Wider Losses in Q1 2026
PremiumCompany Announcements
CSPC Innovation Posts Strong Revenue Growth but Wider Losses in Q1 2026
26d ago
CSPC Wins U.S. FDA Trial Nod for First-in-Class KAT6 Cancer Drug
PremiumCompany Announcements
CSPC Wins U.S. FDA Trial Nod for First-in-Class KAT6 Cancer Drug
29d ago
CSPC Pharmaceutical Moves to Modernize Articles for Paperless, Virtual Governance
PremiumCompany Announcements
CSPC Pharmaceutical Moves to Modernize Articles for Paperless, Virtual Governance
1M ago
CSPC’s Albumin‑Bound Sirolimus Hits Key Goal in Rare Cancer Trial
PremiumCompany Announcements
CSPC’s Albumin‑Bound Sirolimus Hits Key Goal in Rare Cancer Trial
1M ago
CSPC Wins China Trial Nod for New Antibody-Drug Conjugate SYS6051
PremiumCompany AnnouncementsCSPC Wins China Trial Nod for New Antibody-Drug Conjugate SYS6051
1M ago
CSPC Wins Shareholder Approval for Disposal of 30% Stake in Beijing Guoxin Huijin
Premium
Company Announcements
CSPC Wins Shareholder Approval for Disposal of 30% Stake in Beijing Guoxin Huijin
2M ago
CSPC Pharmaceutical Grants 9.46 Million Restricted Shares Under 2018 Award Scheme
Premium
Company Announcements
CSPC Pharmaceutical Grants 9.46 Million Restricted Shares Under 2018 Award Scheme
2M ago
CSPC’s Anbenitamab Combo Hits Phase III Goal in HER2-Positive Breast Cancer
PremiumCompany Announcements
CSPC’s Anbenitamab Combo Hits Phase III Goal in HER2-Positive Breast Cancer
2M ago
CSPC Pharmaceutical Launches 2026 Share Award Scheme as 2018 Plan Nears Limit
PremiumCompany Announcements
CSPC Pharmaceutical Launches 2026 Share Award Scheme as 2018 Plan Nears Limit
2M ago
CSPC Profit Slips but Dividend Rises as China Pharma Shifts to Innovation
PremiumCompany Announcements
CSPC Profit Slips but Dividend Rises as China Pharma Shifts to Innovation
2M ago
CSPC Pharmaceutical Proposes HKD 0.15 Final Dividend for 2025
PremiumCompany Announcements
CSPC Pharmaceutical Proposes HKD 0.15 Final Dividend for 2025
2M ago
CSPC Wins China Approval for New Aprepitant Injection to Strengthen Antiemetic Portfolio
PremiumCompany AnnouncementsCSPC Wins China Approval for New Aprepitant Injection to Strengthen Antiemetic Portfolio
2M ago
CHJTF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CHJTF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CSPC Wins China Trial Nod for Monthly GLP-1/GIP Obesity Drug
Premium
Company Announcements
CSPC Wins China Trial Nod for Monthly GLP-1/GIP Obesity Drug
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >